project

Virtual Biotech

AI agent system from a Stanford Medicine lab that organises tens of thousands of language-model agents into the divisions of a drug-development company, covering target identification, molecular analysis and clinical-trial design.

Known aliases

virtual biotech company

Relationships

No evidence-backed relationships are recorded.

Current clusters

science2 publishers

Stanford's all-agent biotech put one AI agent on each of 37,075 clinical trials

James Zou's agent company read the results of tens of thousands of finished trials and found that drugs aimed at switch-like, cell-type-specific targets reached market about 48% more often. No experiment has tested that yet.

Publishers:nature.comphys.org

Reality

Evidence58
Adoption22
Hype gap+32
Incentives60
Confidence62